about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesNegative regulation of protein phosphatase 2Cbeta by ISG15 conjugationScreening of retroviral cDNA libraries for factors involved in protein phosphorylation in signaling cascadesInhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteinsEndometrial receptivity defects and impaired implantation in diabetic NOD mice.Recognition of interferon-inducible sites, promoters, and enhancers.Coordinated regulation of SIV replication and immune responses in the CNS.Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time.Interferons, signal transduction pathways, and the central nervous system.Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK.Inflammation activates the interferon signaling pathways in taste bud cells.Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infectionAnalysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injectionReversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population.Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1.The interferon signaling network and transcription factor C/EBP-betaInflammation and taste disorders: mechanisms in taste buds.Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine propertiesImmunity to fish rhabdovirusesTranscription control of DAPK.Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis.A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}.Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.Different physiology of interferon-α/-γ in models of liver regeneration in the rat.Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness.
P2860
Q21131160-F9EE5BAD-E59F-44CD-912A-11BE22155BDEQ24298148-53F31706-692A-4EA5-92BE-973D4862CA04Q24794178-CC7C75C2-2221-4946-8322-84C6001491E9Q29620712-642A2DBF-6BE1-4DA9-8D47-17B9BBCE37FDQ30418061-C8E194AC-D19B-4899-B709-24F79DC36D3EQ33274587-65C238A3-C9B2-4955-A48B-DF954C522DABQ33519523-B4199328-75D0-4CBD-BD17-6CC048AE4DD4Q33812026-D51E4270-73DC-4876-90DB-95A07AD2811AQ33988186-C1CA66C9-C679-45F7-A531-F4F5D88BA9D9Q34464075-1840921E-6C12-4C03-AAA5-C8AA49B039DAQ34583489-8C5EC527-9413-45C2-8DB2-B645CEFE4123Q35004930-5B83EC85-77B8-41EC-B82E-E97D93224E53Q35077047-CE4FACC5-8737-460E-9B4C-D0F868BE6B79Q35117727-17293585-9359-422A-B7A1-27E681AE5274Q35382729-FEFFA773-A80F-4F34-B255-099E3B5B702CQ35886748-C82D7073-22FC-4D35-8533-99A4F67AD779Q36308205-C431E1A5-8028-4FC1-B2C1-BDD5FA8131D5Q36540282-346BB37D-C7C6-44C4-8FE1-99467D485146Q37046824-2D5FC377-02B1-49E5-98B3-D4A7AAB000B0Q37312123-2C2654EE-0945-4712-91AC-EC85D26D81D1Q37482664-65D7AFE3-FC25-4B20-9ACE-FFFD875C11D3Q37547088-A714ADD7-90E0-4D91-B425-B9ACBECA446EQ37987133-496DFBE1-D4F3-40FD-B611-C09B4C909D7AQ38161832-64DF11C6-A81D-4EC8-BF68-0D318FE95355Q39832097-378C5263-7E27-472C-949C-918B9C5CB6B7Q40288125-CB7A7F9D-33AA-462E-A5B4-23C7C39E3E43Q40425770-A35048C3-CEC2-45BC-85BA-9A5AE4BA6903Q42813590-FD3CAFA5-5AF9-461D-A068-C88D64E8AC67Q42857638-C2F3405F-9EF7-4A23-906B-3306D4256D47Q42993815-920033EB-B1DE-4249-B736-C032F624D839Q46742743-8CC6BBF8-052A-43B1-BEFC-5D50E2274C18
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Alternate interferon signaling pathways.
@ast
Alternate interferon signaling pathways.
@en
type
label
Alternate interferon signaling pathways.
@ast
Alternate interferon signaling pathways.
@en
prefLabel
Alternate interferon signaling pathways.
@ast
Alternate interferon signaling pathways.
@en
P1476
Alternate interferon signaling pathways.
@en
P2093
Dhananjaya V Kalvakolanu
P356
10.1016/S0163-7258(03)00070-6
P577
2003-10-01T00:00:00Z